CN101380391B - Traditional Chinese medicine external application paste for treating angiitis - Google Patents
Traditional Chinese medicine external application paste for treating angiitis Download PDFInfo
- Publication number
- CN101380391B CN101380391B CN2008101208849A CN200810120884A CN101380391B CN 101380391 B CN101380391 B CN 101380391B CN 2008101208849 A CN2008101208849 A CN 2008101208849A CN 200810120884 A CN200810120884 A CN 200810120884A CN 101380391 B CN101380391 B CN 101380391B
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- chinese medicine
- external application
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine ointment for external application which treats vasculitis and consists of the ingredients with the following mass ratios: 290 to 310 portions of eupolyphaga sinensis, 90 to 110 portions of polygonum cuspidatum, 190 to 210 portions of cowherb seed, 90 to 110 portions of ligusticum wallichii, 140 to 160 portions of radix cynanchi paniculati, 25 to 35 portions of clove, 50 to 70 portions of radix angelicae formosanae, 15 to 25 portions of borneol, 90 to 110 portions of bunge corydalis herb and 140 to 160 portions of stringy stonecrop herb. After being mixed, the ingredients are dried or aired, pulverized and are evenly mixed with erythromycin ointment. The ointment treats diseases by the skin absorption, which has less dosage, takes effect rapidly, addresses both the symptoms and root causes, reduces the pains of patients, has no side effect and is economical and practical.
Description
[technical field]
The present invention relates to the field of Chinese medicines, particularly the vasculitic herbal application cream of external application skin-penetrating therapeutic.
[background technology]
At present clinically be used to treat vasculitis and use anticoagulant therapy, antiagglutination, operative therapy, extract oral etc. mostly.Treatment cycle is long, and cure rate is low, poor prognosis, and very expensive, and it is painful that the patient increases treatment.Existing treatment by Chinese herbs vasculitis; Have severally through patent searching, like application number 200710191993.5 " the vasculitic oral powder of a kind of treatment and external application cream and preparation method thereof ", it carries out with oral and external application simultaneously; Bother; And more expensive with Moschus, Folium Ginseng price, other patents prescriptions are each has something to recommend him, and are different fully with this programme.
[summary of the invention]
The object of the invention solves the problems of the prior art exactly, proposes the vasculitic external application of Chinese medicine cream of a kind of treatment, can make the patient in a short period of time, and motionless operation need not be played sealing, and oral Chinese medicine, Western medicine and fully recover do not alleviate the patient suffering, and be economical and practical.
For realizing above-mentioned purpose, the present invention proposes the vasculitic external application of Chinese medicine cream of a kind of treatment.Form by following component: and each constituent mass proportioning is: 290~310 parts of Eupolyphaga Seu Steleophagas, 90~110 parts of Rhizoma Polygoni Cuspidati, 190~210 parts of Semen Vaccariae, 90~110 parts of Rhizoma Chuanxiongs; 140~160 parts of Radix Cynanchi Paniculatis, 25~35 parts of Flos Caryophyllis, 50~70 parts of the Radixs Angelicae Dahuricae, 15~25 parts of Borneolum Syntheticums; 90~110 parts of Herba Violaes, 140~160 parts of Herba Sedis, said components is dried or is dried after mixing; After pulverize 150 sieves, mix all, process ointment with erythromycin ointment.
As preferred each constituent mass proportioning be: 290 parts of Eupolyphaga Seu Steleophagas, 110 parts of Rhizoma Polygoni Cuspidati, 190 parts of Semen Vaccariae, 110 parts of Rhizoma Chuanxiongs, 140 parts of Radix Cynanchi Paniculatis, 35 parts of Flos Caryophyllis, 50 parts of the Radixs Angelicae Dahuricae, 25 parts of Borneolum Syntheticums, 110 parts of Herba Violaes, 140 parts of Herba Sedis.
As preferred each constituent mass proportioning be: 310 parts of Eupolyphaga Seu Steleophagas, 90 parts of Rhizoma Polygoni Cuspidati, 210 parts of Semen Vaccariae, 90 parts of Rhizoma Chuanxiongs, 160 parts of Radix Cynanchi Paniculatis, 25 parts of Flos Caryophyllis, 70 parts of the Radixs Angelicae Dahuricae, 15 parts of Borneolum Syntheticums, 90 parts of Herba Violaes, 160 parts of Herba Sedis.
Beneficial effect of the present invention: the present invention adopts Eupolyphaga Seu Steleophaga: broken congestion, reuniting the fractured tendons and bones; Rhizoma Polygoni Cuspidati: dampness removing, the broken silt; Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping, antithrombotic, expansion blood vessel; Radix Cynanchi Paniculati: the removing dampness of dispeling the wind, antalgesic-antipruritic; Borneolum Syntheticum: the refreshment etc. of having one's ideas straightened out, 10 flavor Chinese medicines mix, apply on the appearance skin of affected part, the ability blood circulation promoting and blood stasis dispelling, vessel softening, anti-inflammation and sterilization, virus killing are eliminated redness, promoting tissue regeneration and ulcer healing.Recovery from illness within a short period of time.Dosage is few, and instant effect is asked Ben Zhigen.The patient need not performed the operation, palliate the agonizing sufferings, have no side effect, and economical and practical, meet the hommization treatment.
Therapeutic effect: vasculitis 76 examples that are used to treat affected part end ulcer.Treatment time about 30 days, cure rate 95%.A special case wherein: Wenling Mr. Guo suffers from degree of depth vasculitis, on being paralyzed in bed, and a little your name's hospitalizes in Shanghai, many with the methods of wearing stretch socks, invalid back is applied with vasculitis ointment and was fully recovered in three months.
Be used to treat affected part 21 example treatment times of vasculitis of ulcer about two or three months, cure rate 81%, a special case wherein, Changxing Mr. Li; Vasculitis is ulcer, 5 years, several large hospitals in Shanghai, Hangzhou; Fail to respond to any medical treatment, the back was applied five months with vasculitis ointment, fully recovered..
[specific embodiment]
Embodiment one:
300 parts of Eupolyphaga Seu Steleophagas, 100 parts of Rhizoma Polygoni Cuspidati, 200 parts of Semen Vaccariae, 100 parts of Rhizoma Chuanxiongs, 150 parts of Radix Cynanchi Paniculatis, 30 parts of Flos Caryophyllis, 60 parts of the Radixs Angelicae Dahuricae, 20 parts of Borneolum Syntheticums, 100 parts of Herba Violaes, 150 parts of Herba Sedis.Above-mentioned component dries or dries after mixing; Mix all with the erythromycin flexible glue behind the pulverize, become ointment subsequent use, ointment is applied even at affected part at every turn; Changed once in one day; Patient's continuous use that ulcer do not take place general affected part just can be fully recovered in 30 days, to the patient of ulcer, treatment time need can fully recover in three months.
Usage: external, at affected part ointment is applied all at every turn, apply the back and use preservative film, gauze, rubber plaster is fixed, and changes once in one day, to the affected part of ulcer usefulness earlier
Clean wound, the drug of topical application again.
Points for attention: external application, contraindication in pregnancy can not be oral, is not strayed into eyes.
Cure mainly function: eliminating inflammation and expelling toxin, antibacterial, blood circulation promoting and blood stasis dispelling, vessel softening, mediation blood vessels, detumescence and promoting granulation.
Embodiment two:
290 parts of Eupolyphaga Seu Steleophagas, 110 parts of Rhizoma Polygoni Cuspidati, 190 parts of Semen Vaccariae, 110 parts of Rhizoma Chuanxiongs, 140 parts of Radix Cynanchi Paniculatis, 35 parts of Flos Caryophyllis, 50 parts of the Radixs Angelicae Dahuricae, 25 parts of Borneolum Syntheticums, 110 parts of Herba Violaes, 140 parts of Herba Sedis.Said components is dried or is dried after mixing, and transfers all subsequent use with the erythromycin flexible glue after pulverize 150 sieves.
Embodiment three:
310 parts of Eupolyphaga Seu Steleophagas, 90 parts of Rhizoma Polygoni Cuspidati, 210 parts of Semen Vaccariae, 90 parts of Rhizoma Chuanxiongs, 160 parts of Radix Cynanchi Paniculatis, 25 parts of Flos Caryophyllis, 70 parts of the Radixs Angelicae Dahuricae, 15 parts of Borneolum Syntheticums, 90 parts of Herba Violaes, 160 parts of Herba Sedis.Said components is dried or is dried after mixing, and transfers all subsequent use with the erythromycin flexible glue after pulverize 150 sieves.
Claims (4)
1. treat vasculitic external application of Chinese medicine cream for one kind, it is characterized in that: following traditional Chinese medicine raw and weight proportion thereof are: steam 290~310 parts of Eupolyphaga Seu Steleophagas, 90~110 parts of Rhizoma Polygoni Cuspidati, 190~210 parts of Semen Vaccariae; 90~110 parts of Rhizoma Chuanxiongs, 140~160 parts of Radix Cynanchi Paniculatis, 25~35 parts of Flos Caryophyllis, 50~70 parts of the Radixs Angelicae Dahuricae; 15~25 parts of Borneolum Syntheticums, 90~110 parts of Herba Violaes, 140~160 parts of Herba Sedis, above-mentioned raw material of Chinese medicine dries or dries after mixing; Behind the pulverize, mix well, process ointment with erythromycin ointment.
2. the vasculitic external application of Chinese medicine cream of a kind of treatment as claimed in claim 1, it is characterized in that: raw material of Chinese medicine and weight proportion thereof are: steam 300 parts of Eupolyphaga Seu Steleophagas, 100 parts of Rhizoma Polygoni Cuspidati; 200 parts of Semen Vaccariae, 100 parts of Rhizoma Chuanxiongs, 150 parts of Radix Cynanchi Paniculatis; 30 parts of Flos Caryophyllis, 60 parts of the Radixs Angelicae Dahuricae, 20 parts of Borneolum Syntheticums; 100 parts of Herba Violaes, 150 parts of Herba Sedis.
3. the vasculitic external application of Chinese medicine cream of a kind of treatment as claimed in claim 1, it is characterized in that: raw material of Chinese medicine and weight proportion thereof are: steam 290 parts of Eupolyphaga Seu Steleophagas, 110 parts of Rhizoma Polygoni Cuspidati; 190 parts of Semen Vaccariae, 110 parts of Rhizoma Chuanxiongs, 140 parts of Radix Cynanchi Paniculatis; 35 parts of Flos Caryophyllis, 50 parts of the Radixs Angelicae Dahuricae, 25 parts of Borneolum Syntheticums; 110 parts of Herba Violaes, 160 parts of Herba Sedis.
4. like the vasculitic external application of Chinese medicine cream of the described a kind of treatment of claim l, it is characterized in that: raw material of Chinese medicine and weight proportion thereof are: steam 310 parts of Eupolyphaga Seu Steleophagas, 90 parts of Rhizoma Polygoni Cuspidati; 210 parts of Semen Vaccariae, 90 parts of Rhizoma Chuanxiongs, 160 parts of Radix Cynanchi Paniculatis; 25 parts of Flos Caryophyllis, 70 parts of the Radixs Angelicae Dahuricae, 15 parts of Borneolum Syntheticums; 90 parts of Herba Violaes, 160 parts of Herba Sedis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101208849A CN101380391B (en) | 2008-09-11 | 2008-09-11 | Traditional Chinese medicine external application paste for treating angiitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101208849A CN101380391B (en) | 2008-09-11 | 2008-09-11 | Traditional Chinese medicine external application paste for treating angiitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101380391A CN101380391A (en) | 2009-03-11 |
CN101380391B true CN101380391B (en) | 2012-05-23 |
Family
ID=40460561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101208849A Expired - Fee Related CN101380391B (en) | 2008-09-11 | 2008-09-11 | Traditional Chinese medicine external application paste for treating angiitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101380391B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1413722A (en) * | 2002-10-25 | 2003-04-30 | 岳喜杰 | Chinese patent drug for treating thrombus obliterating angiitis |
-
2008
- 2008-09-11 CN CN2008101208849A patent/CN101380391B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1413722A (en) * | 2002-10-25 | 2003-04-30 | 岳喜杰 | Chinese patent drug for treating thrombus obliterating angiitis |
Non-Patent Citations (2)
Title |
---|
史容姣.血栓闭塞性脉管炎与动脉硬化症的辨治.《辽宁中医杂志》.2004,(第04期),307-308. * |
赵媛越.中医药治疗血栓闭塞性脉管炎近况.《天津中医学院学报》.1997,(第02期),44-45. * |
Also Published As
Publication number | Publication date |
---|---|
CN101380391A (en) | 2009-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1259382A (en) | Dissolvable granula prepn. prepd. from forgythia fruit and honeysuckle | |
CN1278446A (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
CN1055013C (en) | Method for prepn. of Chinese medicinal external application ointment for diminishing inflammation, stopping pain and setting fracture | |
CN101983710A (en) | Medicine for external application in orthopedics, production method and application method thereof | |
CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
CN1883575A (en) | Chinese medicine for treating hyperosteogeny | |
CN103385985B (en) | Chinese herbal medicine composition for quick connection of muscles and bones | |
CN102614452B (en) | Chinese medicinal composition for effectively treating scleroderma | |
CN101380391B (en) | Traditional Chinese medicine external application paste for treating angiitis | |
CN103394042A (en) | Traditional Chinese medicine tincture used for adjuvant therapy on bone fracture | |
CN103100010A (en) | Drug for treatment of rheumatic arthritis | |
CN112972557A (en) | Medicinal liquor for treating arthralgia and myalgia and preparation method thereof | |
CN105435210A (en) | Traditional Chinese medicine oriented permeable drug treatment liquid for treating cold-dampness stasis type lumbar disc herniation and preparation method thereof | |
CN1106279A (en) | Painless bonesetting medicine | |
CN101269194B (en) | Medicament tincture for treating scobination type prurigo and preparation method thereof | |
CN1273104A (en) | Chinese medicine for treating hepatitis B and hepatic fibrosis and its preparing process | |
CN103720973A (en) | Chinese herbal medicine for treating lumbar disc herniation and preparation method thereof | |
CN103566245B (en) | A kind of medicine for the treatment of nephropathy | |
CN104027451B (en) | A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica | |
CN101607007B (en) | Traditional Chinese medicine preparation for treating cerebral circulation insufficiency | |
CN102068534B (en) | Chinese medicinal composition for relaxing tendons and activating collaterals and preparation method thereof | |
CN106474325A (en) | A kind of Chinese medicine preparation for treating cervical spondylopathy and waist dish outstanding and preparation method thereof | |
CN101485826A (en) | Chinese medicament preparation for treating rheumatism and rheumatoid disease | |
CN105663850A (en) | Traditional Chinese medicine composition for treating oral ulcer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20140911 |
|
EXPY | Termination of patent right or utility model |